Cryoport, Inc. (CYRX) KPIs and segments
Close on Nov 13, 2026Market cap $1.01BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Cryoport's business
Cryoport's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aggregate of reportable segment($M) | 50.2 | 44.2 | 44.5 | 46.0 | 41.4 | 40.6 | 38.6 | 40.1 | 37.5 | ||||
Life Sciences Services($M) | 28.2 | 27.4 | 26.5 | 25.5 | 25.8 | 23.2 | 22.6 | 21.3 | |||||
Life Science Supply Chain Solutions($M) | 25.8 | 23.2 | 21.6 | 19.9 | |||||||||
Life Sciences Products($M) | 20.8 | 20.4 | 19.0 | 18.7 | 19.6 | 17.8 | 18.9 | 17.0 | |||||
Life Science Systems($M) | 19.6 | 17.8 | 18.1 | 17.4 | |||||||||
Service($M) | 28.0 | 26.9 | 25.0 | 24.3 | 24.4 | 22.9 | 21.5 | 20.9 | 20.2 | 19.5 | 37.0 | 36.0 | |
BioLogistics Solutions($M) | 22.4 | 21.7 | 20.3 | 19.4 | 19.9 | 18.5 | 17.5 | 17.0 | 16.6 | 16.0 | 33.4 | 32.5 | |
Product($M) | 21.0 | 20.9 | 20.4 | 20.0 | 21.1 | 18.2 | 20.0 | 17.4 | 19.6 | 17.8 | 20.2 | 20.1 | |
BioStorage/BioServices($M) | 5.61 | 5.23 | 4.70 | 4.83 | 4.50 | 4.33 | 4.00 | 3.98 | 3.52 | 3.53 | 3.62 | 3.54 | |
Earlier reporting (last reported 2023)3 | |||||||||||||
Americas($M) | 36.9 | 35.0 | 32.7 | 33.1 | 33.2 | 32.2 | 29.6 | 27.8 | 29.4 | 26.7 | 21.5 | 31.6 | |
Europe, the Middle East, and Africa (EMEA)($M) | 8.03 | 8.95 | 7.09 | 6.63 | 5.83 | 5.58 | 6.89 | 6.20 | 6.53 | 7.40 | 13.4 | 14.2 | |
Asia Pacific (APAC)($M) | 4.05 | 3.89 | 5.68 | 4.46 | 6.38 | 3.27 | 4.97 | 4.28 | 3.76 | 3.20 | 13.0 | 10.4 | |
Life Sciences Products($M) | 4.29 | 3.67 | 3.28 | 3.50 | 4.01 | 3.51 | 4.23 | 2.83 | |||||
Life Science Systems($M) | 4.01 | 3.51 | 3.51 | 2.12 | |||||||||
Life Sciences Services($M) | 1.65 | -0.10 | -0.28 | 1.60 | -0.05 | -2.48 | -1.97 | -1.55 | |||||
Life Science Supply Chain Solutions($M) | -0.05 | -2.48 | -4.02 | -4.94 | |||||||||
Service($M) | 14.0 | 13.2 | 12.1 | 12.1 | 11.9 | 10.9 | 10.5 | 10.1 | 9.41 | 8.47 | 15.1 | 15.2 | |
Product($M) | 8.86 | 8.76 | 9.57 | 9.27 | 9.46 | 7.70 | 9.00 | 7.33 | 8.26 | 6.59 | 8.17 | 9.05 | |
9 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-06.
See a number that looks wrong?